Category: Zacks Small Cap Research
By David Bautz, PhDNASDAQ:MTFBREAD THE FULL MTFB RESEARCH REPORTBusiness UpdateCRL for IclaprimOn February 14, 2019, Motif Bio Plc (NASDAQ:MTFB) announced that the U.S. FDA issued a complete response letter (CRL) for the new drug application (NDA) fo ...
By David Bautz, PhDNASDAQ:MNOVREAD THE FULL MNOV RESEARCH REPORTBusiness UpdateAdvancing MN-166 to Phase 3 for Progressive MS and ALSMediciNova, Inc. (NASDAQ:MNOV) is currently developing MN-166 (ibudilast) for a number of indications, with the lead ...
By Steven Ralston, CFATSX:WML.VOTC:WMLLFREAD THE FULL RESEARCH REPORT HEREWealth Minerals (TSX:WML.V) (OTC:WMLLF) is a junior mineral exploration company that is well-positioned to benefit from its portfolio of prospective lithium projects in the Lit ...
By David Bautz, PhDREAD THE FULL RESEARCH REPORT HERE NASDAQ:SNGXBusiness UpdateInnate Defense Regulators Offer Novel Means to Treat InfectionsSoligenix, Inc. (NASDAQ:SNGX) recently published a review of the potential clinical applications for innate ...
By David Bautz, PhDNASDAQ:AGRXREAD THE FULL RESEARCH REPORT HEREBusiness UpdateAdhesion Study SuccessfulOn February 11, 2019, Agile Therapeutics, Inc. (NASDAQ:AGRX) announced positive topline results for the comparative adhesion study that tested the ...
By Steven Ralston, CFANASDAQ:DSKEREAD THE FULL DSKE RESEARCH REPORTEXECUTIVE SUMMARY OF RECENT EVENTS‣ On February 7th, Daseke (NASDAQ:DSKE) preannounced select financial results for the fourth quarter and year ending December 31, 2018 and management ...
By John Vandermosten, CFANASDAQ:TTNPWe have now had more than two full quarters of in-house management of Probuphine commercialization by Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and indications are that shipment trends are strong. Since the company ...
By Steven Ralston, CFAOTC:PQEFF | TSX:PQEREAD THE FULL PQEFF RESEARCH REPORTPetroteq Energy (OTC:PQEFF) (TSX:PQE) is an upstream exploration and production (E&P) company focused on advancing its proprietary Clean Oil Recovery Technology (CORT). C ...
By John Vandermosten, CFANYSE:CVMREAD THE FULL CVM RESEARCH REPORTWe are initiating coverage of CEL-SCI Corporation (NYSE:CVM) with a $14.00 price target based on our estimates for a 2021 US and 2022 EU launch of lead compound Multikine in squamous c ...
By Steven Ralston, CFANASDAQ:MNGAREAD THE FULL MNGA RESEARCH REPORTMagneGas (NASDAQ:MNGA) / Taronis Technologies produces, sells and distributes a clean, hydrogen-based fuel synthesized through its proprietary, patented Plasma Arc Flow™ process. Curr ...